ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: PO0709

Exogenous Hydrogen Sulfide Protects Kidneys of Diabetic Mice from Oxidative Injuries

Session Information

Category: Diabetic Kidney Disease

  • 601 Diabetic Kidney Disease: Basic

Authors

  • Chen, Xueqi, The Core Laboratory,Nanjing BenQ Medical Center,The Affiliated BenQ Hospital of Nanjing Medical University,Nanjing,China, Nanjing, China
  • Xiao, Leijuan, Department of Nephrology,Nanjing BenQ Medical Center,The Affiliated BenQ Hospital of Nanjing Medical University,Nanjing,China, Nanjing, China
  • Ren, Zhiyun, The Core Laboratory,Nanjing BenQ Medical Center,The Affiliated BenQ Hospital of Nanjing Medical University,Nanjing,China, Nanjing, China
  • Wang, Weiwan, The Core Laboratory,Nanjing BenQ Medical Center,The Affiliated BenQ Hospital of Nanjing Medical University,Nanjing,China, Nanjing, China
  • Jia, Yutao, The Core Laboratory,Nanjing BenQ Medical Center,The Affiliated BenQ Hospital of Nanjing Medical University,Nanjing,China, Nanjing, China
  • Yu, Yanting, The Core Laboratory,Nanjing BenQ Medical Center,The Affiliated BenQ Hospital of Nanjing Medical University,Nanjing,China, Nanjing, China
  • Wang, Xiaoyan, The Core Laboratory,Nanjing BenQ Medical Center,The Affiliated BenQ Hospital of Nanjing Medical University,Nanjing,China, Nanjing, China

Group or Team Name

  • The Core Laboratory for Clinical Research
Background

Exogenous hydrogen sulfide (H2S) protects kidneys from diabetic injuries in animal models. In order to explore its mechanisms, we determined the effects of H2S donor on renal reactive oxygen species (ROS) related enzymes in diabetic mice.

Methods

Male C57Bl/6J mice (8 weeks old) were intraperitoneally injected with STZ at 50mg/kg/day for 6 days. GYY4137 (20 mg/kg/day in 6 ml of drinking water,GYY+DM group, n=5) or vehicle (6 ml of drinking water, DM group, n=4) plus 60% fat diet were fed the mice 2 weeks after the initial STZ injection when blood glucose remained high relative to background mice. The 2 groups of diabetic mice were injected with long-acting insulin (10U/kg) weekly at week 3.

Results

GYY4137 ameliorated albuminuria and hyperglycemia at weeks 8 & 10. Serum insulin and creatinine were similar in the diabetic mice. Renal morphologic structures (HE, Massson, PAS) were improved by GYY4137 at week 10 when the mice were sacrificed. Renal nitrotyrosine (protein oxidative injury marker) was decreased along with the decrease of laminin (early fibrosis marker) in GYY+DM mice relative to DM mice (western blotting). NOX2, NOX4 were lower but NOS 1,HO2, PON1,PON2 were higher in GYY+DM than those in DM group. NOS2,NOS3, NOX1 ,HO1, SOD1-3 and COX1 were similar between groups. The levels of mRNA were not in agreement with the changes in proteins with all enzymes but HO2.

Conclusion

Our findings suggest that exogenous H2S may decrease ROS production and increase ROS cleavage in kidney via the affected enzymes, thus improve the renal oxidative damage in diabetic nephropathy.